(Vancouver, British Columbia) – Will diabetic foot ulcer and venous leg ulcer treatment be easier to get in the future? How will manufacturers adjust to the growing demands and unstable future of reimbursement for skin substitutes? These are the types of questions iData Research set out to answer in their latest study on the U.S.
iData ResearchLeg and Foot Ulcer Treatment Could Get Cheaper for Diabetics in the U.S.
Register to receive a free Wound and Tissue Management Market Report Suite 2019 synopsis and brochure Traditionally, surgical wounds have been closed with sutures, staples, Steri-strips, Mastisol, or some combination thereof. There are multiple benefits to using these technologies, but new products are expected to significantly improve the way surgeons close wounds. Ethicon’s Dermabond Prineo mesh and cyanoacrylate-based skin closure systems, as well
iData ResearchNew Wound Closure Technology Set To Triple In Value By 2025, Cannibalize Competitors
Register to receive a free US Market Report Suite for Wound and Tissue Management report synopsis and brochure Stryker announced the acquisition of privately-held HyperBranch Medical Technology, Inc. for a total equity value of approximately $220 million in an all-cash transaction. HyperBranch is dedicated to developing medical devices based on its proprietary polymers and cross-linked hydrogels. Its
iData ResearchStryker Acquires HyperBranch Medical Technology, Inc.
Register to receive a free Europe Market Report Suite for Wound and Tissue Management report synopsis and brochure Australian stem cell and regenerative medicine company Cynata Therapeutics Limited is pleased to announce that it has received positive data demonstrating the efficacy of its Cymerus™ mesenchymal stem cells (MSCs) in a preclinical model of diabetic wounds (also
iData ResearchCynata’s Cymerus™ MSCs Effective in Preclinical Model of Diabetic Wounds
Register to receive a free Europe Market Report Suite for Wound and Tissue Management report synopsis and brochure Smith & Nephew released the results from a trial of its Allevyn Life multi-layer silicone adhesive foam dressing, touting that its addition to standard care protocols reduces the onset of pressure ulcers by 71% in elderly patients being treated for
iData ResearchSmith & Nephew Touts Results From Allevyn Life Adhesive Dressing Hip Fracture Trial
Gecko Biomedical (“Gecko”), a medical device company developing innovative polymers to support tissue reconstruction, announced today that it has received CE Mark approval for its SETALUM™ Sealant allowing the company to market its technology in Europe.
iData ResearchGecko Biomedical Receives CE Mark Approval for SETALUM Sealant